Dr. Benjamin Otte is a Jber, Alaska based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Benjamin Otte is 0101273156 for Ophthalmology in Virginia. Dr. Benjamin Otte is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Benjamin Otte speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
673 Mdg, 5955 Zeamer Avenue, Jber, Alaska, 99506
Phone:
907-580-1162
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1548896319
NPI Enumeration Date:
12 Mar, 2020
NPI Last Update On:
06 Aug, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Benjamin Otte are as mentioned below.
License Number
Specialization
State
Status
0101273156
Ophthalmology
Virginia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
673 Mdg, 5955 Zeamer Avenue Jber, Alaska
Zip:
99506
Phone Number:
907-580-1162
Fax Number:
--
Patients can reach Dr. Benjamin Otte at 673 Mdg, 5955 Zeamer Avenue, Jber, Alaska or can call to book an appointment on 907-580-1162. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.